<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="858">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>13/09/2005</approvaldate>
  <nctid>NCT00206531</nctid>
  <trial_identification>
    <studytitle>The Role of Naive T-Cells in HIV Pathogenesis</studytitle>
    <scientifictitle>Role of Naive T-Cells in the Pathogenesis of T-Cell Decline and Long Term Persistence of HIV</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>114/05</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>HIV Infections</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Acquired immune deficiency syndrome (AIDS / HIV)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes />
  <eligibility>
    <inclusivecriteria>Part 1:

        - HIV positive by ELISA and Western Blot VL &gt;2,000, CD4 &gt;350

        Part 2:

          -  HIV positive by ELISA and Western Blot

          -  Established Chronic infection (15 individuals)

          -  Acute infection (15 individuals).

          -  Any viral load or CD4 count.

          -  No therapy.

          -  Any individual who initiates HAART as determined by the treating physician</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration>Longitudinal</duration>
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Bayside Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>While HIV mainly infects mature T-cells it can also infect newly produced (or naïve) T-cells.
      These infected naïve T cells may then act a viral reservoir even in patients with
      undetectable viral loads. Understanding when and how these cells are infected is important
      because it could help us to understand why patients fail therapy even if they have a
      persistently undetectable viral load.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00206531</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Sharon R Lewin</name>
      <address>Director, Infectious Diseases Unit, The Alfred Hospital</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Sharon R Lewin</name>
      <address />
      <phone>+61 3 9276 3009</phone>
      <fax />
      <email>S.Lewin@alfred.org.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>